| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | 1 | — | — | 2 | — | — | 2 | 1 | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2024 | ‡‡‡ |
|
| 2023 | ‡‡‡ |
|
| 2022 | ‡‡‡ |
|
| 2021 | ‡‡‡ |
|
| 2020 | ‡‡‡ |
|
| 2019 | ‡‡‡ |
|
| 2017 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 102.80 | 103.09 | 128.12 | 142.78 |
| Receivables | 75.08 | 69.41 | 81.43 | 96.46 |
| Inventory | 13.66 | 12.31 | 14.40 | 15.41 |
| Other | — | — | — | — |
| 200.66 | 194.85 | 233.54 | 266.24 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 15.64 | 15.50 | 15.10 | 21.54 |
| ST’ Debt | — | — | — | — |
| Other | — | — | — | — |
| 49.68 | 53.27 | 67.00 | 73.20 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 139.34 | 149.34 | — | — |
—
|
| ’25 | 126.21 | 135.06 | 135.37 | 136.49 |
533.13
|
| ’24 | 127.89 | 125.63 | 125.62 | 121.75 |
500.89
|
| ’23 | 125.86 | 122.27 | 130.71 | 125.05 |
503.88
|
| ’22 | 124.17 | 126.90 | 121.72 | 115.61 |
488.40
|
| ’21 | 116.13 | 123.05 | 125.34 | 123.58 |
488.10
|
| ’20 | 115.11 | 106.58 | 107.50 | 105.21 |
434.40
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 17.54 | 15.44 | — | — |
—
|
| ’25 | 18.38 | 10.58 | 29.09 | 16.45 |
74.50
|
| ’24 | 21.34 | 14.44 | 24.75 | 17.29 |
77.83
|
| ’23 | 22.58 | 9.29 | 24.18 | 17.23 |
73.27
|
| ’22 | 17.78 | 13.26 | 20.52 | 10.52 |
62.08
|
| ’21 | 6.43 | 14.30 | 11.50 | 23.02 |
55.24
|
| ’20 | 22.41 | 31.01 | 28.96 | 24.59 |
106.97
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 15.28 | 9.24 | — | — |
—
|
| ’25 | 17.12 | 9.12 | 25.84 | 8.42 |
60.50
|
| ’24 | 18.77 | 10.25 | 23.20 | 16.46 |
68.69
|
| ’23 | 19.33 | 6.33 | 21.14 | (0.95) |
45.86
|
| ’22 | 14.71 | 10.30 | 13.37 | 6.12 |
44.50
|
| ’21 | (0.12) | (3.08) | 7.47 | 16.76 |
21.03
|
| ’20 | 8.99 | 11.12 | 21.77 | 18.07 |
59.96
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.33 | 0.37 | — | — |
—
|
| ’25 | 0.15 | 0.18 | 0.30 | 0.25 |
0.88
|
| ’24 | 0.20 | 0.18 | 0.29 | (0.02) |
0.66
|
| ’23 | 0.10 | (0.01) | 0.31 | 0.27 |
0.66
|
| ’22 | 0.19 | 0.09 | 0.14 | (4.24) |
(3.77)
|
| ’21 | 0.13 | 0.47 | 0.17 | 0.43 |
1.21
|
| ’20 | 0.52 | 0.47 | 0.55 | 0.36 |
1.89
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 22.04 | 23.01 | 25.76 | 29.59 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 61.14 | 40.47 | 45.15 | 55.90 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,568 | 2,415 | 2,357 | 2,280 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.19 | 0.21 | 0.21 | 0.23 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 488.40 | 503.88 | 500.89 | 533.13 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 44.12% | 44.06% | 44.56% | 44.48% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (97.88) | 27.95 | 24.67 | 31.06 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (20.04%) | 5.55% | 4.93% | 5.83% | ‡‡‡ | ‡‡‡ | — |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (103.46) | 17.22 | 16.59 | 21.24 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 39.43 | 37.53 | 35.81 | 33.81 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17.82 | 19.24 | 19.96 | 22.29 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | (3.77) | 0.66 | 0.66 | 0.89 | ‡‡‡‡‡ | ‡‡‡‡ | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.26 | 2.80 | 3.10 | 3.11 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.64) | (1.05) | (0.36) | (0.59) | ‡‡‡ | ‡‡‡ | — |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.62 | 1.75 | 2.74 | 2.53 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 25.45 | 26.55 | 26.70 | 28.17 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 27.41 | 26.19 | 25.10 | 23.92 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.00 | 56.72 | 59.23 | 56.84 | ‡‡‡‡ | ‡‡‡‡ | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.42 | 1.97 | 1.96 | 2.27 | ‡‡‡ | ‡‡‡ | — |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.99 | 1.43 | 1.46 | 1.80 | ‡‡‡ | ‡‡‡ | — |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.30 | 1.81 | 1.79 | 2.06 | ‡‡‡ | ‡‡‡‡ | — |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.26 | 19.87 | 13.05 | 18.19 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 62.08 | 73.27 | 77.83 | 74.50 | ‡‡‡ | ‡‡‡ | — |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (17.58) | (27.42) | (9.13) | (14.01) | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 44.50 | 45.86 | 68.69 | 60.50 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 114.99 | 150.98 | 141.58 | 166.54 | — | — | — |
Working Cap'
|
| — | ‡‡‡‡‡ | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 21.35 | 0.60 | 0.29 | — | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (58.77) | (102.21) | (102.80) | (128.12) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 697.65 | 695.30 | 670.15 | 673.93 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (11.96%) | 2.19% | 2.19% | 2.82% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (9.59%) | 2.97% | 2.19% | 2.88% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (13.56%) | 2.47% | 2.43% | 3.16% | — | — | — |
ROE
|
Proto Labs (PRLB), a pioneer in on-demand digital manufacturing, shows resilient recovery with revenue approaching $500 million annually and strong free cash flow per share surging 56% to $2.74 in 2024, fueled by workforce optimization and the asset-light Hubs network acquired in 2021. Despite gross margin compression to 45% from pandemic-era highs and a volatile history—including a 92% stock plunge in 2022—recent insider buys by the CEO and a director signal executive confidence amid stabilizing ROIC at 2.2% and a pristine $103 million net cash position.
Trading at a 23% premium to analyst mean targets, PRLB’s forward projections dazzle with 6.6% revenue CAGR to $607 million by 2026, EPS climbing 22% to $1.42, and potential ROIC expansion to 5%+ from Hubs synergies and AI manufacturing tailwinds. Yet, high P/E ratios and margin risks from supply chain frictions warrant caution, as statistical models flag 25% odds of growth faltering below 5%. This balanced thesis—overweight for patient investors eyeing 20-30% EPS upside—unpacks deeper correlations and probabilistic edges in the full analysis.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.